BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7568120)

  • 1. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer.
    Reuss FU; Coffin JM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9293-7. PubMed ID: 7568120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.
    Reuss FU; Coffin JM
    J Virol; 1998 Jul; 72(7):6073-82. PubMed ID: 9621071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
    Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
    Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
    Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
    J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative-acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat.
    Wintersperger S; Salmons B; Miethke T; Erfle V; Wagner H; Günzburg WH
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2745-9. PubMed ID: 7708717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ; Lozano M; Binhazim AA; Dudley JP
    J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells.
    Mukhopadhyay R; Medina D; Butel JS
    Virology; 1995 Aug; 211(1):74-93. PubMed ID: 7645239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
    Krummenacher C; Diggelmann H; Acha-Orbea H
    J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
    Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
    Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
    Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
    Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements.
    Reuss FU; Coffin JM
    J Virol; 2000 Sep; 74(17):8183-7. PubMed ID: 10933730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
    Yanagawa S; Murakami A; Tanaka H
    J Virol; 1990 Jun; 64(6):2474-83. PubMed ID: 2159524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.
    Golovkina TV; Dudley JP; Jaffe AB; Ross SR
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer.
    Wang Y; Pelisson I; Melana SM; Holland JF; Pogo BG
    Int J Oncol; 2001 May; 18(5):1041-4. PubMed ID: 11295054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements.
    Mink S; Ponta H; Cato AC
    Nucleic Acids Res; 1990 Apr; 18(8):2017-24. PubMed ID: 2159634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies.
    Etkind PR; Stewart AF; Dorai T; Purcell DJ; Wiernik PH
    Clin Cancer Res; 2004 Sep; 10(17):5656-64. PubMed ID: 15355890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.
    Mustafa F; Lozano M; Dudley JP
    J Virol; 2000 Oct; 74(20):9431-40. PubMed ID: 11000212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.